Integrated Filing — IndAS



General information about company

Scrip Code 507205
NSE Symbol TI
MSEI Symbol NOTLISTED
ISIN INE133E01013
Name of company Tilaknagar Industries Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 13-11-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 08-11-2025
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Manufacturing and sale of IMFL
Start date and time of board meeting 13-11-2025   14:35:00
End date and time of board meeting 13-11-2025   16:28:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
1 Income
Revenue from operations 91,558.90 1,77,945.85
Other income 215.10 640.89
Total income 91,774.00 1,78,586.74
2 Expenses
(a) Cost of materials consumed 20,618.19 41,477.20
(b) Purchases of stock-in-trade 0.00 0.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (13.35) (1,195.27)
(d) Employee benefit expense 1,641.98 3,042.64
(e) Finance costs 209.62 490.54
(f) Depreciation, depletion and amortisation expense 734.22 1,462.78
(f) Other Expenses
1 Excise Duty 51,736.54 97,209.47
2 Other Expenses 11,555.43 21,945.56
Total other expenses 63,291.97 1,19,155.03
Total expenses 86,482.63 1,64,432.92
3 Total profit before exceptional items and tax 5,291.37 14,153.82
4 Exceptional items 0.00 0.00
5 Total profit before tax 5,291.37 14,153.82
6 Tax expense
7 Current tax 0.00 0.00
8 Deferred tax 0.00 0.00
9 Total tax expenses 0.00 0.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 5,291.37 14,153.82
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method (23.61) (35.31)
16 Total profit (loss) for period 5,267.76 14,118.51
17 Other comprehensive income net of taxes (1.13) (29.93)
18 Total Comprehensive Income for the period 5,266.63 14,088.58
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 5,266.63 14,118.51
Total profit or loss, attributable to non-controlling interests 0.00 0.00
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent (1.13) (29.93)
Total comprehensive income for the period attributable to owners of parent non-controlling interests 0.00 0.00
21 Details of equity share capital
Paid-up equity share capital 20,819.38 20,819.38
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 2.71 7.28
Diluted earnings (loss) per share from continuing operations 2.69 7.21
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 2.71 7.28
Diluted earnings (loss) per share from continuing and discontinued operations 2.69 7.21
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) Notes to the Consolidated Unaudited Results for quarter and half year ended September 2025 1 The above consolidated results have been reviewed by the Audit Committee and approved by the Board of Directors at its Meeting held on November 13, 2025. The Statutory Auditors have expressed qualified opinion. 2 The above results have been prepared in accordance with Indian Accounting Standards (Ind AS) prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India. 3 The above results have been prepared by the Company in accordance with IND-AS 110: Consolidated Financial Statements and IND-AS 28: Accounting for Investments in Associate in Consolidated Financial Statements prescribed under Section 133 of the Companies Act, 2013 and other accounting principles generally accepted in India. 4 The Group is predominantly engaged in the business of manufacture and sale of Indian Made Foreign Liquor (IMFL) and its related products, which constitute a single business segment as per IND-AS 108: Operating Segments. Accordingly, disclosure in accordance with the provisions of Circular issued by the SEBI on July 05, 2016 is not applicable. 5 The Parent Company expects to restart the grain distillery plant post incurring of relevant capital expenditure. In view of this, the management believes that there is no impairment in value of its ENA Plant and hence the recoverable amount of the ENA Plant is not required to be estimated. 6 The Revenue from Operations includes Rs 3,862.27 lacs for the quarter ended June 30, 2025 Rs 1,035.74 lacs for the quarter ended September 30, 2024, Rs 3862.27 lacs for the half year ended September 30, 2025, Rs 1592.13 lacs for the half year ended September 30, 2024 and Rs 2,901.09 lacs for the year ended March 31, 2025 received as partial Subsidy from Government of Maharashtra under Package Scheme of Incentives, 2007, relating to past investments. 7 During the quarter ended September 2025, the Company continued to progress on its follow-on investment in Spaceman Spirits Lab Private Limited (“SSL”), makers of premium Indian craft gin Samsara and craft rum Sitara. As previously disclosed, the Company had entered into a Share Subscription and Investment Agreement on September 09, 2024 for a total investment commitment of Rs. 13.15 crores to be completed in three tranches. The first tranche of Rs 399.99 lacs was completed on September 20, 2024.Pursuant to the agreement (read with the Second Supplementary Agreement dated August 06, 2025), the Company has during the quarter disbursed the second and third tranches aggregating to Rs. 915.00 lacs. Further, on August 06, 2025, the Finance Committee of the Board of Directors approved an acquisition of 2,236 equity shares of SSL from an existing shareholder at a price of Rs. 6,765.79 per share, aggregating to a total consideration of Rs. 151.28 lacs vide its Share Purchase Agreement dated August 06, 2025. Post completion of the aforementioned investments, the Company’s shareholding in SSL stands increased to 21.36% on a fully diluted basis. The Company has accordingly accounted for its share of losses from SSL of Rs. 2.31 lacs in the financial results for the quarter and half year ended September 30, 2025. The investments are aligned with the Company’s strategy to expand its presence in the premium craft spirts segment and build a strong portfolio in high-potential categories. 8 A body corporate has filed a suit in Bombay High Court in 2009 regarding ownership of two of the brands owned by the Company, and the Company has filed a counter claim in this regard. The Court in its order dated Dec 22, 2011 has adjudicated in favor of the Company and allowed unrestricted usage of the concerned brands throughout India by the Company. An appeal had been filed by the body corporate against the order dated Dec 22, 2011. Vide an order dated 16th July, 2025 passed by the Division Bench of the Bombay High Court, the said appeal filed by the body corporate has been dismissed and the Court has deemed it fit to upheld the order dated 22nd December, 2011 in favour of the Company. In a separate application filed in the counter claim, the Court in its order dated Feb 7, 2025 had given approval to the assignee of the body corporate to also use the name of the concerned brand in West Bengal. The Company believed it has strong case in its favor and had filed an appeal with the Division Bench of Bombay High Court against the said order. The Bombay High Court has put a stay on the order dated Feb 7, 2025, and subsequently an undertaking has been given by the assignee of body corporate that it will not act upon the order dated Feb 7, 2025. Vide an order dated 16th July, 2025 the Division Bench of Bombay High Court has allowed the appeal filed by the Company and set aside the order dated 7th February, 2025 passed by the Single Bench. Further, the Body Corporate had challenged the order dated 16th July, 2025, at Supreme Court. The Hon’ble Supreme Court of India has vide an order passed on 16th September, 2025, upheld the Order dated July 16, 2025 passed by the Division Bench of the Hon’ble Bombay High Court in favour of the Company (TI) and disposed off the Special Leave Petitions filed by UTO Nederland B.V. As a result of which the body corporate and its assignee are now restrained from using the name of the concerned brand until the final decision of the suit and the Supreme Court has ordered for the suit to be expedited. The Company continues its uninterrupted exclusive use and sale of the goods under the said brand. 9a Acquisition of Imperial Blue Business Division from Pernod Ricard India Private Limited : In July 2025, the Company and / or Grain & Grape Works Private Limited, a Wholly Owned Subsidiary of the Company entered into a Business Transfer Agreement (BTA) along with ancillary agreements to acquire the Business Undertaking of Pernod Ricard India Private Limited, as a going concern on a slump sale basis, related to the business of production, bottling, marketing and sale of alcoholic and other beverages under the Imperial Blue Brands (IB), for a lump sum consideration of EUR 413 million (approx Rs 4,150 crores), subject to the adjustments in accordance with the terms and conditions set out in the above agreements. The consideration also includes deferred consideration of EUR 28 million (approx Rs 282 crores), to be paid after four years from the date of closure of the transaction. The proposed transaction includes acquisition of the IB brands, with 22.4 million 9-litre cases sold in the year ended March 2025 across India and other markets, including two owned units and services from co-manufacturing bottlers across India. The Competition Commission of India has by its letter dated October 07, 2025 approved the proposed combination under Section 31(1) of the Competition Act, 2002. The transaction is expected to be consummated by the end of the ongoing third quarter. The Company will fund the aforementioned acquisition through a mix of debt and equity. 9b During the quarter ended September 30, 2025, the Company has allotted the issue of 1,43,80,000 Equity Shares of face value Rs. 10/- each (“Equity Shares”) for cash at a price of Rs. 382/- per equity share (including a premium of Rs. 372/- per equity share) for an amount aggregating to Rs. 5,49,31,60,000/- to the persons belonging to the non-promoter category on a preferential basis. Further the Company has issued 4,57,15,000 Convertible Warrants (“Warrants”) for cash at a price of Rs. 382/- per warrant (including a premium of Rs. 372/- per Warrants) for an amount aggregating to Rs. 1,746,31,30,000/- to the persons belonging to the promoter & non-promoter category on a preferential basis. An amount equivalent to 25% of the Total warrant price was received by the company during the quarter ended September 30, 2025. 10 Update on Expansion Plans of Wholly Owned Subsidiary – M/s. Prag Distillery (P) Ltd. (Prag) The Office of the Commissioner of Distilleries & Breweries, Andhra Pradesh, Vijayawada has extended the validity of the Letter of Intent (LOI) issued earlier for Grant of Expansion License for augmentation of Bottling capacity by 200 lakh proof litres (approx 30 lac cases per annum), in favour of Prag at its factory in Andhra Pradesh, subject to compliance with applicable rules and payment of LOI fees along with interest till the date of payment and obtaining the Expansion License up to August 31, 2025. The Holding Company has approved the expansion project and subsequently paid Rs 33.04 crores towards LOI fees and accrued interest on August 4, 2025 and Rs 2.00 crores on August 26, 2025. Further, during the quarter, the Company has considered and approved a capital expenditure of Rs. 25 crores for Prag to enhance its existing bottling capacity. 11 The Standalone and Consolidated unaudited financial results of the Company for the quarter and half year ended September 30, 2025 are available on the Company’s website www.tilind.com) and on the website of BSE (www.bseindia.com) and NSE (www.nseindia.com). 12 The previous period figures have been regrouped and reclassified wherever necessary.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 30-09-2025
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 35,568.05
Capital work-in-progress 4,026.52
Investment property 0.00
Goodwill 0.00
Other intangible assets 35.58
Intangible assets under development 0.00
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 0.00
Non-current financial assets
Non-current investments 3,166.14
Trade receivables, non-current 0.00
Loans, non-current 2.50
Other non-current financial assets 3,722.95
Total non-current financial assets 6,891.59
Deferred tax assets (net) 0.00
Other non-current assets 2,623.71
Total non-current assets 49,145.45
2 Current assets
Inventories 17,312.31
Current financial asset
Current investments 35.49
Trade receivables, current 45,802.91
Cash and cash equivalents 82,972.43
Bank balance other than cash and cash equivalents 29,454.89
Loans, current 0.47
Other current financial assets 635.13
Total current financial assets 1,58,901.32
Current tax assets (net) 0.00
Other current assets 7,593.20
Total current assets 1,83,806.83
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 2,32,952.28
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 20,819.38
Other equity 1,78,303.56
Total equity attributable to owners of parent 1,99,122.94
Non controlling interest
Total equity 1,99,122.94
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 499.32
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities 3,709.29
Total non-current financial liabilities 4,208.61
Provisions, non-current 541.14
Deferred tax liabilities (net) 0.00
Deferred government grants, Non-current 0.00
Other non-current liabilities 0.00
Total non-current liabilities 4,749.75
Current liabilities
Current financial liabilities
Borrowings, current 4,225.05
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 5,082.40
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 9,696.31
Total Trade payable 14,778.71
Other current financial liabilities 3,951.27
Total current financial liabilities 22,955.03
Other current liabilities 956.87
Provisions, current 5,167.69
Current tax liabilities (Net) 0.00
Deferred government grants, Current 0.00
Total current liabilities 29,079.59
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 33,829.34
Total equity and liabilites 2,32,952.28
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2025 01-04-2025
Date of end of reporting period 30-09-2025 30-09-2025
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement gain /(loss) in respect of the defined benefit plans -113000 -2993000
Total Amount of items that will not be reclassified to profit and loss (1.13) (29.93)
2 Income tax relating to items that will not be reclassified to profit or loss 0.00 0.00
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income (1.13) (29.93)



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 30-09-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 14,153.82
Adjustments for reconcile profit (loss)
Adjustments for finance costs 490.55
Adjustments for decrease (increase) in inventories (787.85)
Adjustments for decrease (increase) in trade receivables, current (4,792.46)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets 0.00
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current (1,381.94)
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 0.00
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 0.00
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 1,462.78
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 0.00
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current (1,710.54)
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains (8.12)
Adjustments for dividend income 0.00
Adjustments for interest income 495.17
Adjustments for share-based payments 89.07
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 154.80
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) (6,978.88)
Net cash flows from (used in) operations 7,174.94
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 210.01
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 6,964.93
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 1,066.29
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 0.00
Purchase of property, plant and equipment 3,788.62
Proceeds from sales of investment property 850.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 203.58
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (20,453.32)
Net cash flows from (used in) investing activities (24,254.65)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 98,726.54
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 1,000.00
Repayments of borrowings 476.24
Payments of lease liabilities 41.61
Dividends paid 0.01
Interest paid 452.85
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (67.75)
Net cash flows from (used in) financing activities 98,688.08
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 81,398.36
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents 81,398.36
Cash and cash equivalents cash flow statement at beginning of period 1,574.07
Cash and cash equivalents cash flow statement at end of period 82,972.43